Top Social Impact Companies (5,249)

Market Expansion: National and payer footprint have broadened materially, with availability across all 50 states, plan relationships rising toward 100+, and sharp increases in providers, patients, and appointments. This widening reach indicates an ability to capture demand across geographies and insurance lines.

Investor Backing & Capital Strength: A $100M Series D at a roughly $2.3B valuation alongside substantial prior financing reflects strong access to growth capital. This position supports continued scaling of the network, product investments, and deeper insurer integrations.

Strong Revenue Growth: Revenue is described as having increased significantly over a recent 12‑month period, with earlier disclosures citing outsized year‑over‑year gains. Coupled with rising session volumes, this points to robust top‑line momentum despite limited public financial detail.

Strong Revenue Growth: Revenue is consistently rising at double-digit rates, including about 26% growth in 2025 and 22%–28% year-over-year gains across early 2026. Company disclosures also highlight increasing payers and monetization, reinforcing the revenue trajectory.

Market Expansion: International rollout accelerated across Europe and Latin America in 2025–2026, with entries into additional countries and leadership in downloads across several expansion markets. European expansion-market revenue rose sharply year over year, evidencing traction beyond core English-speaking geographies.

Strong Market Position & Advantage: The app maintains a top-tier standing among dating platforms, including #1 download positions in select European markets and a top-three rank in the U.S. Consistent MAU and payer growth alongside high download ranks indicate strengthening competitive footing.

Strong Revenue Growth: Revenue is described as having exceeded 40% year over year in 2022 and 273% growth over the Deloitte Fast 500 measurement period. Recent disclosures cite well over $100M in ARR and reporting of more than $100M in annual revenue.

Market Expansion: Customer footprint is reported at 3,500+ organizations across 150+ countries, with earlier periods adding 600+ customers and a London office opened to support rapid international growth. Partnerships and channel integrations are noted as expanding reach to multinational programs.

Product Line Growth: The platform has broadened through AI-powered launches (assistants, analytics, plan builders) and the acquisition of Pyrra to add social/digital threat intelligence. Continued investment in 2026, including new leadership roles focused on AI, underscores ongoing product expansion.

Product Line Growth: Newer businesses such as Pharma Direct and subscriptions are expanding rapidly, with clear momentum highlighted in 2026. Investment is being shifted toward these lines to replace slower legacy revenue.

Future-Ready Strategy: Management is prioritizing Pharma Direct and subscription products and raised 2026 revenue guidance, signaling a transition aimed at restoring overall growth. These segments are described as the main engines expected to offset declines in the legacy business.

Profitability: Profitability remains solid even as the top line fluctuates, including positive GAAP earnings and substantial adjusted EBITDA in Q2 2026. Operating cash flow also strengthened, supporting continued execution.

Market Expansion: District reach has expanded from 1,000+ around the 2021 acquisition to 1,900+ by early 2026, with coverage across 50+ states and over half of U.S. EL students. This indicates broadening geographic penetration and customer footprint.

Product Line Growth: The offering has evolved from EL program management and instructional tools into a unified ELD platform that now includes benchmark assessment via the 2026 Ellevation Benchmark launch. This broader scope points to increased relevance and potential expansion within existing districts.

Strong Market Position & Advantage: The company is frequently described as a leading, specialized provider in its EL/MLL niche, serving 1,900+ districts and 2.5M+ learners. Such penetration suggests a defensible position within its targeted category.

Strong Revenue Growth: Revenue is reported to have risen from 2024 to 2025, with an annualized run rate later surpassing the $125–$130 million range. This momentum is highlighted alongside increases in customer usage and overall scale.

Profitability: The company achieved its first annual net profit (around $3 million), indicating healthier unit economics and improving financial stability. This marks a shift from earlier periods focused on rebuilding.

Market Expansion: Operations expanded into 19 new states in 2025, bringing total coverage to roughly 33–34 states. New offerings such as Possible Advance further extended product reach and addressable market.

Strong Revenue Growth: Revenue has surged, with ClassWallet reporting more than doubled revenue in FY2022 and multi‑year growth rates of 916%, 1,217%, and 610% across successive Inc. 5000 periods. Business booked reached more than $1.1B in 2022 as transaction volume rose 158%.

Market Expansion: Operations have broadened from 27 to 37 states, while cumulative funds distributed climbed to about $6.5B alongside growth in clients, programs, and users. New statewide contracts in 2025, including Ohio’s selection and Indiana’s expansion, reinforce ongoing geographic growth.

Investor Backing & Capital Strength: The company closed a $95M institutional growth-capital round in 2023, with trackers citing roughly $102.6M in total funding. The financing was explicitly positioned to support continued expansion.

Strong Revenue Growth: Revenue is depicted as rising dramatically, including an increase from $3.6M in 2021 to $617.4M in 2024 and subsequent commentary citing a roughly $1B run rate.

Investor Backing & Capital Strength: Capital access appears robust, highlighted by a $150M Series D in 2026 at an approximately $3B valuation and total funding near $328M from prominent investors.

Market Expansion: Geographic and channel reach is expanding, with 26,000+ clinicians across all 50 states, 125+ insurance partners (including Medicare and Medicaid), and movement into employer and health‑system partnerships.

Market Expansion: Geographic reach is described as nationwide through Medicare, with pages indicating coverage in 48 to all 50 states, signaling active expansion. State-by-state therapist listings and nationwide positioning reinforce a broad and growing footprint.

Product Line Growth: Service scope expanded from therapy for older adults to a broader platform that includes behavioral health, advocacy, wellness classes, mind exercises, and AI care agents. This indicates growth beyond the original core offering.

Strong Hiring & Retention: Headcount and hiring activity are depicted as rising quickly, with quarter-over-quarter increases reported by company intelligence trackers and ongoing recruiting across clinical and corporate roles. This workforce build-out supports scaling operations.

Investor Backing & Capital Strength: Funding is described as including a $30M Series B led by Andreessen Horowitz, bringing total backing to about $50M, signaling strong capital support for scaling. Investor commentary highlights conviction in Camber’s execution and claims-data advantage.

Market Expansion: Operations are reported to have broadened from an initial behavioral-health focus into additional care verticals and across all 50 states, alongside rising claims volume and provider reach. Company materials cite millions of claims processed and coverage of large billable amounts.

Strong Hiring & Retention: Hiring activity is ongoing, with the company described in the 51–200 employee range and noting its biggest hiring quarter in 2025. Open roles and expansion of enterprise go-to-market roles indicate continued team scaling.

Innovation-Driven Growth: Product development is described as continuously expanding — AI recruiting (e.g., Beaker), an Action Center, advanced analytics/insights, and an integrations marketplace — signaling innovation as a growth lever. These capabilities are presented as helping distributed businesses streamline hiring and deepen platform use.

Strategic Partnerships: Partnerships with major automotive OEM programs (e.g., Ford and GM dealerships) and ecosystem integrations (e.g., Indeed, ADP, UKG) are highlighted as extending distribution and customer reach. These ties reinforce go-to-market channels within core verticals.

Market Expansion: Expansion beyond automotive into healthcare and hospitality, plus the EmployUs acquisition, is noted alongside growth in users and substantial platform throughput. Company updates also indicate customers are broadening usage across sourcing, hiring, and onboarding.

Product Line Growth: The company has expanded beyond its paper‑sharing model by operating Academia.edu Journals, listing 24 journals with more than 1,300 articles. This signals deliberate growth into scientific publishing alongside the core platform.

Investor Backing & Capital Strength: A $23 million Series D in 2022 brought total reported investment to $63 million. This financing underpins continued scaling and product expansion.

Strong Market Position & Advantage: The platform is repeatedly characterized as a leading academic social‑networking and research‑sharing site alongside ResearchGate, supported by a very large registered‑user base and extensive hosted content. Recent third‑party estimates also show substantial ongoing web traffic at tens of millions of monthly visits.

Strong Revenue Growth: Inclusion on the Inc. 5000 list in both 2025 and 2026 is cited as direct evidence of multi‑year revenue growth. Consecutive recognition implies sustained top‑line expansion over the measured period.

Market Expansion: Partner counts rose from about 140+ colleges and universities across 33 states in 2025 to 160–180+ partners across 34 states by 2026. New statewide and institutional engagements in places such as Michigan, New Jersey, Massachusetts, and additional colleges indicate a widening geographic footprint.

Strategic Partnerships: State‑level programs (for example, New Jersey’s statewide re‑enrollment marketplace and Michigan’s multi‑institution initiative) show deepening relationships beyond single campuses. Ongoing additions like Montgomery County Community College and Mineral Area College reflect continued partner acquisition.

Strong Revenue Growth: Revenue is characterized as surging, with a high placement on the 2026 Inc. 5000 list for multi‑year expansion. Company materials also state revenue has doubled or tripled annually across its history, though these figures are not from audited financials.

Investor Backing & Capital Strength: Capital resources appear substantial, with more than $100M raised and a Series C closed in April 2025. Prominent venture backing and stated plans for continued hiring support capacity to fund scale.

Market Expansion: Operating footprint is described as broadening, with 1,000+ clients served daily and 100,000+ annually, and expansion beyond Social Security Disability into workers’ compensation. The lawyer network grew from 30 to 86 partner firms, indicating wider coverage and capacity.

Strong Market Position & Advantage: Adoption spans 1,300+ biotechnology organizations with usage reported across more than half of the top 50 biopharma companies, signaling durable positioning in life‑sciences R&D software. Multiple sources characterize the platform as a leading life‑sciences R&D cloud used by both startups and major enterprises.

Product Line Growth: The company continues to launch and expand major offerings, including Benchling AI, antibody‑discovery capabilities, automation/analysis tools, and extensions into new scientific workflows such as small‑molecule chemistry. Acquisitions like PipeBio further broaden capability depth in biologics and related R&D domains.

Innovation-Driven Growth: AI is a clear growth vector, with reports that 500 biotech companies used Benchling AI in its first year and the product subsequently reached general availability. Team acquisitions (e.g., ReSync Bio and Sphinx Bio) and partnerships (e.g., with Anthropic) underscore a deliberate push to embed advanced models into scientific workflows.

Strong Revenue Growth: TechCrunch reported that revenue increased six-fold year over year as of May 2025, indicating rapid top-line acceleration.

Market Expansion: The company expanded from 5 states in 2023 to 18 states in 2025 and announced nearly 25 states by February 2026, pointing to broadening geographic coverage.

Investor Backing & Capital Strength: The company closed a $55 million Series B in May 2025, bringing total funding to about $125 million. The round was led by General Catalyst with participation from Andreessen Horowitz, GV, and Accel, underscoring access to capital.

Market Expansion: The platform’s footprint expanded from 400 participating sites in 2022 to 6,000+ sites by 2026, with presence across 50+ countries and 25+ sponsors. Evidence indicates marketplace adoption more than doubled in 2023 and activity surpassed 100 trials by 2024.

Product Line Growth: The offering broadened from a marketplace into AI-powered patient pre-screening and integrated workflows, with reported operational time savings and enrollment improvements in case studies. Subsequent integrations with CRIO, RealTime eClinical, and eClinPro signal continued platform expansion.

Strategic Partnerships: Relationships include major pharmaceutical organizations (e.g., 16 of the top 30 in 2024 and now 25+ sponsors) and ecosystem deals such as RealTime eClinical (50+ networks representing 2,000+ sites) plus CRIO/eClinPro integrations. These ties appear to extend distribution and enrich data used for site selection and enrollment.

Profitability: Earnings are characterized as record in 2025 with further year-over-year gains into the first half of 2026, indicating improved bottom-line strength. Profit growth is highlighted alongside higher operating income and strong net income trends.

Strong Revenue Growth: Revenue is increasing on a multi-year basis, with 2025 at a record and both Q1 and Q2 2026 marking record quarters despite uneven quarterly momentum. Guidance still points to higher full-year revenue versus 2025.

Future-Ready Strategy: Management is pursuing a bank acquisition and new product expansion to broaden the platform and support future growth. Updates to underwriting models are also emphasized to improve risk management and operational scalability.

Strong Revenue Growth: Revenue is rising sharply, with Q2 2026 at about $71M (+37% YoY) and H1 2026 at $138.8M versus $83.8M in the comparable 2025 period. Sequential gains from late 2025 into 2026 reinforce the growth trajectory.

Profitability: Segment profitability is evident, including roughly $22.9M adjusted EBITDA in Q1 2026 and reported net earnings in 2025. Management guidance pointing to $50–$60M of adjusted EBITDA for 2026 suggests scale efficiencies are emerging.

Strong Market Position & Advantage: Scale and positioning are reinforced by 1.6–1.7 million paying subscribers, rising ARPU, and operation as Upbound’s fastest-growing segment. The acquisition and dedicated segment reporting underscore strategic relevance and competitive standing.

Investor Backing & Capital Strength: New capital in July 2026—$10M of a planned larger round with an SEC Form D filing—signals renewed financial support, with cumulative funding reported around $52.9M. This underpins ongoing rebuild and expansion efforts.

Market Expansion: Operations span Florida, Ohio, Michigan, Virginia, and Washington, with multiple local offices indicating a substantial multi-state footprint. Reported coverage of 45,000 attributed lives across multiple states points to meaningful scale in these markets.

Strong Hiring & Retention: Company materials and LinkedIn indicate a 201–500 employee range with active recruiting, including peer-support roles. Hiring activity in 2026 aligns with expansion across several states.